# Use of Sodium Stibogluconate as a Treatment for Leishmaniasis

> **NCT00657618** · PHASE1,PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 77 (actual)

## Conditions studied

- Leishmaniasis

## Interventions

- **DRUG:** Sodium Stibogluconate (SSG)

## Key facts

- **NCT ID:** NCT00657618
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2010-04
- **Final completion:** 2015-04
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657618, "Use of Sodium Stibogluconate as a Treatment for Leishmaniasis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00657618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*